Salicylic Acid

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of common warts and plantar warts. Common warts are characterized by a rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for up to 5 minutes to facilitate treatment. After soaking, the area must be dried completely.

Using the provided applicator, one drop of the medication should be carefully applied to each wart, ensuring that the wart is sufficiently covered. It is important to allow the application to dry completely before proceeding.

This procedure may be repeated once or twice daily as necessary, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

• Patients with diabetes or poor blood circulation, due to the increased risk of complications.

• Application on genital warts or warts located on the face or mucous membranes is prohibited to avoid potential adverse effects.

• The product should not be used on moles, birthmarks, or warts with hair growth, as these may require different management.

• Avoid application on irritated skin or any area that is infected or reddened, as this may exacerbate the condition.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame to prevent any risk of ignition.

The use of this product is contraindicated in certain populations and conditions. It should not be used by individuals with diabetes or those who have poor blood circulation. Additionally, it is not recommended for application on genital warts, warts located on the face or mucous membranes, moles, birthmarks, or warts that have hair growing from them. The product should also be avoided on irritated skin or any area that is infected or reddened.

Healthcare professionals should advise patients to discontinue use and consult a physician if discomfort persists after application.

To ensure safety, this product must be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

While using this product, if it comes into contact with the eyes, it is crucial to flush the eyes with water for at least 15 minutes. Users should also avoid inhaling vapors to minimize respiratory irritation. The bottle should be capped tightly and stored at room temperature, away from heat sources to maintain product integrity and safety.

Side Effects

Patients should be aware that this product is for external use only. It is contraindicated for individuals who are diabetic or have poor blood circulation. Additionally, the product should not be applied to genital warts, warts on the face or mucous membranes, moles, birthmarks, or warts with hair growing from them. It is also not recommended for use on irritated skin or any area that is infected or reddened.

During the use of this product, if it comes into contact with the eyes, it is essential to flush the eyes with water for 15 minutes. Patients should avoid inhaling vapors and ensure that the bottle is tightly capped and stored at room temperature, away from heat sources.

Patients are advised to discontinue use and consult a healthcare professional if discomfort persists. Furthermore, this product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (liquid wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should not use this product if they have diabetes or poor blood circulation. The safety of this product during pregnancy has not been established, and it is contraindicated for use on genital warts, warts on the face or mucous membranes, moles, birthmarks, or warts with hair growing from them. Additionally, it should not be applied to irritated skin or any area that is infected or reddened.

Healthcare professionals should advise pregnant patients to avoid this product due to the lack of safety data and the potential risks associated with its use. The product is for external use only and is flammable; therefore, it should be kept away from fire or flame.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, no data are provided concerning the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the lack of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are advised to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

It is important to inform patients that this product should not be used by individuals who are diabetic or have poor blood circulation. Additionally, patients should be cautioned against using the product on genital warts, warts on the face, or mucous membranes. They should also avoid applying it to moles, birthmarks, or warts that have hair growing from them, as well as on irritated skin or any area that appears infected or reddened.

Patients should be advised to discontinue use and consult a doctor if discomfort persists. When using this product, healthcare providers should instruct patients to flush the eyes with water for 15 minutes if the product comes into contact with them. They should also be warned to avoid inhaling vapors and to ensure that the bottle is capped tightly and stored at room temperature, away from heat sources.

Storage and Handling

The product is supplied in a container that must be stored at a temperature range of 20°C to 25°C (68°F to 77°F). It is essential to keep the container tightly closed to prevent solidification. After each use, the top of the bottle should be wiped clean to maintain hygiene and product integrity.

Care should be taken to avoid contact with surrounding skin during application. Additionally, the product should not come into contact with fabrics, floors, countertops, or other surfaces, as it may cause staining. It is also important to keep the product away from fire or flame.

The product should be discarded when signs of the wart no longer appear.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)